|
||||||
Executive Summary Summary Fertin Pharma A/S (Fertin Pharma) is a pharmaceutical company that develops and manufactures medicated chewing gum. The company offers pharmaceutical chewing gum products for therapeutic areas such as allergy, cough and cold, nicotine replacement, gastrointestinal, pain and oral care, among others. It also provides nutraceuticals for therapeutic areas such as energy, cell protection, bone health, eye health, immunity, multivitamin, oral care, relaxation, and weight management, among others. Fertin Pharma uses Medichew, a multi-layered compressed chewing gum technology. The company also offers contract manufacturing of chewing gum. Fertin Pharma is headquartered in Vejle, Denmark. Fertin Pharma AS-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope - Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios. - Business Description-A brief description of the company's operations. - Key Employees-A list of the key executives of the company. - Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors-A list of the key competitors of the company. - Key Recent Developments-A brief on recent news about the company. Reasons to buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Read More Contact Us:
Table of Contents Table of Contents 3 List of Tables 4 List of Figures 4 Fertin Pharma A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 Fertin Pharma A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6 Fertin Pharma A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 Fertin Pharma A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8 Fertin Pharma A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9 Fertin Pharma A/S, Pharmaceuticals & Healthcare, Deal Details 10 Private Equity 10 EQT Mid Market Acquires 70% Stake in Fertin Pharma from Bagger-Sorensen 10 Licensing Agreements 11 Fertin Pharma Enters into License and Supply Agreement with Pierre Fabre 11 Fertin Pharma Enters into License, Distribution and Supply Agreement with Pierre Fabre 12 Fertin Pharma A/S-Key Competitors 13 Fertin Pharma A/S-Key Employees 14 Fertin Pharma A/S-Locations And Subsidiaries 15 Head Office 15 Appendix 16 Methodology 16 About GlobalData 16 Contact Us 16 Disclaimer 16 List of Figures Fertin Pharma A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2 Fertin Pharma A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2 Fertin Pharma A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2 Fertin Pharma A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2 Fertin Pharma A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 Fertin Pharma A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6 Fertin Pharma A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 Fertin Pharma A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8 List of Tables Fertin Pharma A/S, Pharmaceuticals & Healthcare, Key Facts 2 Fertin Pharma A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 Fertin Pharma A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6 Fertin Pharma A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 Fertin Pharma A/S, Deals By Therapy Area, 2012 to YTD 2018 8 Fertin Pharma A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9 EQT Mid Market Acquires 70% Stake in Fertin Pharma from Bagger-Sorensen 10 Fertin Pharma Enters into License and Supply Agreement with Pierre Fabre 11 Fertin Pharma Enters into License, Distribution and Supply Agreement with Pierre Fabre 12 Fertin Pharma A/S, Key Competitors 13 Fertin Pharma A/S, Key Employees 14 Single User License: Site License: Corporate User License: |
select a license |
||
NEWSLETTER BY CATEGORY
|
||
Testimonials
|
||
The report was very informative and gives me an interesting view on the Indian market.... "Area Sales Manager, Muhlen Sohn GmbH & Co. KG"We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help... "Group Vice President Strategy, Aliaxis"I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again... "Technical Marketing Manager, Ascendis Health Limited"I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ... "., Coldwell Banker - Riyadh "The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future... "International and Business Dev. Director, Duta Abadi Primantara" |